Generic name:COVID-19 Vaccine, mRNA
Dosage form: injection, for intramuscular use
Drug class:Viral vaccines
What is Comirnaty?
Comirnaty is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech.
- It is approved as a 2-dose series for the prevention of COVID-19 in individuals 16 years of age and older.
- It is also authorized under Emergency Use Authorization (EUA) to be administered to provide:
- a two-dose primary series in individuals 12 through 15 years;
- a third primary series dose in individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise; and
- a single booster dose to individuals 12 years of age and older who have completed a primary series with Pfizer-BioNTech COVID-19 Vaccine or Comirnaty (COVID-19 Vaccine, mRNA)
- a single booster dose to individuals 18 years of age and older who have completed primary vaccination with a different authorized COVID-19 vaccine. The booster schedule is based on the labeling information of the vaccine used for the primary series.
COVID-19 is a disease caused by infection from the coronavirus SARS-CoV-2. COVID-19 is predominantly a respiratory illness that can affect other organs. Symptoms range from mild symptoms through to severe illness leading to death. Common symptoms include fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea.
The vaccine has been shown to prevent COVID-19 following 2 doses given 3 weeks apart. The duration of protection against COVID-19 is currently unknown.
What is the difference between Comirnaty and the Pfizer-BioNTech COVID-19 Vaccine?
Comirnaty and the Pfizer-BioNTech COVID-19 Vaccine have the same formulation and can be used interchangeably to provide the COVID-19 vaccination ser..
